Expert opinions on pharmacological symptomatic treatment of behavioral symptoms in frontotemporal dementia: A survey of the Neuropsychiatric International Consortium on Frontotemporal Dementia (NIC‐FTD)
Our survey revealed diverse pharmacological treatment practices for behavioral symptoms in bvFTD, reflecting the expected radical heterogeneity in pharmacological treatment strategies. Notwithstanding this, results from this explorative survey could further inform future research directions, and thus in turn potentially aid in establishing more consensus on effective pharmacological management of bvFTD, while the field awaits the development of highly anticipated disease-modifying treatment(s).
Authors
- Dirk van Paassen
- Alexander Santillo (ORCID: https://orcid.org/0000-0001-9717-0820)
- Everard G.B. Vijverberg (ORCID: https://orcid.org/0000-0003-3879-884X)
- Yolande A.L. Pijnenburg (ORCID: https://orcid.org/0000-0003-2464-1905)
- Simon Ducharme (ORCID: https://orcid.org/0000-0002-7309-1113)
- Sterre de Boer
- Luc Hartog
Institutions
- Montreal Neurological Institute and Hospital (CA)
- The University of Sydney (AU)
- Lund University (SE)
- Douglas Mental Health University Institute (CA)
- Amsterdam Neuroscience (NL)
- McGill University (CA)
- Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- European Journal of Neurology
- Published
- 2024-11-28
- DOI
- https://doi.org/10.1111/ene.16537
- Citations
- 4
- Primary Topic
- Psychiatric care and mental health services
- Type
- article
- Field-Weighted Citation Impact
- 2.56